Covaxin will get Good Manufacturing Practice certificates in Hungary

Covaxin, the indigenously developed vaccine towards Covid-19, has obtained a certificates of Good Manufacturing Practice (GMP) from Hungary’s National Institute of Pharmacy and Nutrition.
The certificates of GMP is now listed on the EudraGMDP, a database of the European Community of producing authorizations and certificates of GMP.

Bharat Biotech intends to submit documentation for Emergency Use Authorization (EUA) in a number of extra international locations worldwide, an official assertion issued on Wednesday stated.
“The recognition complements our commitment to driving world-class innovation and being a frontrunner in the research and development of vaccines,” a press release from Bharat Biotech stated.